Call for research proposals, 2015 Deadline: April 1, 2015
DEBRA International is now inviting expressions-of-interest for funding support of clinical research and clinical trials targeting therapy development and symptom-relief for epidermolysis bullosa (EB). There is a two-stage application process, with a submission deadline for stage 1 proposals (expressions of interest) on 1 April 2015.
Proposals are invited which make a breakthrough in developing therapies that address the underlying causes or the life-limiting consequences of EB (e.g. EB-related squamous cell carcinoma), or in developing symptom-relief treatments that address clinical consequences of EB that impact upon quality of life.